Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001387131-23-013017
Filing Date
2023-11-02
Accepted
2023-11-02 16:50:52
Documents
1
Period of Report
2023-10-23

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES dorbin-form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES dorbin-form4.xml 4 4095
  Complete submission text file 0001387131-23-013017.txt   5740
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
DMK PHARMACEUTICALS Corp (Issuer) CIK: 0000887247 (see all company filings)

EIN.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARCIMOTO, INC. 2034 WEST 2ND AVENUE EUGENE OR 97402
Business Address
Dorbin John W. Jr. (Reporting) CIK: 0001829413 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36242 | Film No.: 231373281